RemeGen Co. Ltd. Class A

As of December 31, 2025, RemeGen Co. Ltd. Class H carries a market capitalization of 7.87B, placing it among publicly traded companies globally. Its enterprise value stands at 7.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

RemeGen Co. Ltd. Class H's next confirmed earnings release is scheduled for October 29, 2026.

As of December 31, 2025, RemeGen Co. Ltd. Class H has 1.01B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, RemeGen Co. Ltd. Class H maintains a current ratio of 1.43, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, RemeGen Co. Ltd. Class H's stock has declined approximately 28.10% over the past 52 weeks. The 50-day moving average sits at 8.36, while the 200-day moving average is 9.26.

As of December 31, 2025, RemeGen Co. Ltd. Class H holds 288.48M in cash and equivalents against 267.98M in total debt, resulting in a net debt position of 122.20M. Total book value stands at 439.25M, with working capital of 144.79M providing operational flexibility.